KLK3 and posterior cortical atrophy: Though the use of prostate-specific antigen screening has improved the detection rate of PCa (Welch & Albertsen, 2009) and reduced the mortality risk of PCa, it did not improve all-cause mortality rates (Fenton et al., 2018; Schröder et al., 2012).